25th Mar 2009 16:30
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
We hereby inform you that on 24 March 2009, the interest of the following individuals, who are all persons discharging managerial responsibilities, in AstraZeneca PLC Ordinary Shares of $0.25 each, changed as detailed below. The change in interest relates to the vesting of previously announced awards made in March 2006 under the AstraZeneca Performance Share Plan or, for Jeff Pott and Lynn Tetrault, the AstraZeneca Executive Performance Share Plan, whereby, following the application of performance measures specified at the time of grant, the individuals concerned have now become beneficially entitled to a percentage of the shares originally awarded. In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed. In each case, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting. The interests of Jeff Pott, Lynn Tetrault and Tony Zook are in the Company's American Depositary Shares (ADSs). One ADS equals one Ordinary Share.
|
Name |
Number of Shares Awarded |
Vesting Percentage |
Number of Shares Lapsed |
Number of Shares Vested |
Number of Shares Withheld |
Net Number of Shares |
|
Bruno Angelici |
26,781 |
89% |
2,946 |
23,835 |
9,773 |
14,062 |
|
Jan Lundberg |
18,475 |
89% |
2,032 |
16,443 |
9,537 |
6,906 |
|
Jeff Pott |
2,020 |
75% |
505 |
1,515 |
490 |
1,025 |
|
Lynn Tetrault |
4,221 |
75% |
1,055 |
3,166 |
1,025 |
2,141 |
|
Tony Zook |
37,624 |
89% |
4,139 |
33,485 |
14,197 |
19,288 |
The market price of AstraZeneca PLC Ordinary Shares of $0.25 each on 24 March 2009 was 2287 pence. The market price of AstraZeneca ADSs on 24 March 2009 was $33.31.
A C N Kemp
Company Secretary
25 March 2009
Related Shares:
Astrazeneca